The Technical Analyst
Select Language :
Verona Pharma plc [VRNA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Verona Pharma plc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Verona Pharma plc is listed at the  Exchange

-3.21% $15.97

America/New_York / 28 mar 2024 @ 15:17


Verona Pharma plc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1 284.66 mill
EPS: -0.720
P/E: -22.18
Earnings Date: May 06, 2024
SharesOutstanding: 80.44 mill
Avg Daily Volume: 0.523 mill
RATING 2024-03-28
B+
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -22.18 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-3.77x
Company: PE -22.18 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$3.51
(-78.01%) $-12.46
Date: 2024-03-28
Expected Trading Range (DAY)

$ 15.09 - 16.95

( +/- 5.79%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-04 Fisher Andrew Buy 0
2024-02-01 Zaccardelli David Sell 480 200 Ordinary Shares
2024-02-01 Rickard Kathleen A. Sell 72 768 Ordinary Shares
2024-02-05 Rickard Kathleen A. Sell 36 248 Ordinary Shares
2024-02-01 Poll Claire Sell 103 408 Ordinary Shares
INSIDER POWER
-43.05
Last 97 transactions
Buy: 4 737 944 | Sell: 13 958 810

Forecast: 16:00 - $15.97

Live Trading Signals (every 1 min)

Forecast 1: 15:26 - $16.00
Forecast 2: 16:00 - $15.97
Forecast 3: 16:00 - $15.97
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $15.97 (-3.21% )
Volume 0.178 mill
Avg. Vol. 0.523 mill
% of Avg. Vol 33.99 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Verona Pharma plc

Last 12 Months

Last 12 months chart data with high, low, open and close for Verona Pharma plc

RSI

Intraday RSI14 chart for Verona Pharma plc

Last 10 Buy & Sell Signals For VRNA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$16.25N/AActive
Profile picture for
            Verona Pharma plc

VRNA

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

Last 10 Buy Signals

Date Signal @
CARTMar 28 - 15:1637.08
XRAYMar 28 - 15:14$33.28
MLKUSDMar 28 - 15:100.411
POOLXUSDMar 28 - 15:085.25
ABTUSDMar 28 - 15:081.940
HNTUSDMar 28 - 15:08$6.13
NTRSMar 28 - 15:05$88.62
DLTRMar 28 - 15:05$133.24
FSLRMar 28 - 15:04$168.29
FWONKMar 28 - 15:04$66.20

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.